Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
Vita Coco Company, Inc. (COCO) Chief Operating Officer Jonathan Burth reported option exercises and share sales of company stock. On 11/17/2025, he exercised 17,666 stock options at an exercise price of $10.178 per share and sold 17,666 common shares in a separate transaction at a weighted average price of $48.684 per share under a Rule 10b5-1 trading plan. The same day, he exercised an additional 20,000 options at $10.178 per share and sold 20,000 shares at a weighted average price of $50.019 per share. Following these transactions, he directly held 76,127 shares of common stock and a significant number of vested and unvested non-qualified stock options with various exercise prices and expiration dates.
Vita Coco Company, Inc. (COCO)5,102 shares of common stock was executed at $44 per share. After this trade, Kirban beneficially owns 127,629 shares directly, 1,479,049 shares indirectly through the Michael Kirban 2010 Trust, and 615,681 shares indirectly through the Michael Kirban Revocable Trust.
Kirban also holds several non-qualified stock options, including 546,000 options with a $10.178 exercise price expiring 12/16/2029 and other grants with exercise prices ranging from $15 to $32.78 and expirations through 03/03/2035. Some options are fully vested and currently exercisable, while others vest in four equal annual installments starting on specified dates.
Vita Coco Company, Inc. (COCO)10,000 shares of common stock at an exercise price of $10.178 per share and then sold 10,000 shares at a weighted average price of $43.7226 per share under a Rule 10b5-1 trading plan. Following these transactions, the reporting person beneficially owned 12,162 shares of common stock directly and held 20,675 stock options, which are fully vested and currently exercisable, with an expiration date of 12/16/2029.
Vita Coco Company, Inc. (COCO) director Ira Liran reported open‑market sales of company stock executed under a Rule 10b5‑1 trading plan. On 11/05/2025, he sold a total of 50,000 shares in two tranches: 20,000 shares at a weighted‑average price of $41.404 and 30,000 shares at a weighted‑average price of $41.407. The sales were completed across multiple transactions within the disclosed price range.
Following these transactions, Liran beneficially owns 538,341 shares directly and 662,579 shares indirectly through the Ira Liran 2012 Family Trust.
Vita Coco (COCO) reported an insider transaction by its Chief Marketing Officer, Jane Prior. On 10/29/2025, she exercised 10,000 stock options at $10.178 per share and, on the same day, sold 10,000 shares at an average price of $45.242. The sales were made pursuant to a Rule 10b5-1 trading plan.
Following these transactions, she beneficially owns 123,666 shares directly. The filing also lists multiple outstanding non‑qualified stock option grants with various exercise prices and expiration dates.
Vita Coco Company, Inc. (COCO) director Ira Liran reported the sale of 40,000 shares of common stock on 10/29/2025 under a Rule 10b5-1 trading plan. The weighted average sale price was $45.577, with individual transactions ranging from $44.07 to $48.00.
Following the transactions, Liran held 558,341 shares directly and 692,579 shares indirectly through the Ira Liran 2012 Family Trust.
Vita Coco (COCO) Executive Chairman and Director Michael Kirban reported open‑market sales made under a Rule 10b5‑1 trading plan. He sold 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average price of $44.211 on 10/30/2025.
The 10/30 transactions occurred in multiple trades between $44.00 and $45.00. Following the reported sales, beneficial ownership reported included 1,484,151 shares held indirectly by the Michael Kirban 2010 Trust, plus 127,629 shares held directly and 615,681 shares held indirectly by the Michael Kirban Revocable Trust.
Reported derivative holdings include non‑qualified stock options to purchase 546,000 shares at $10.178 expiring 12/16/2029 (fully vested), 298,507 shares at $15 expiring 10/21/2031, and 70,715 shares at $32.78 expiring 03/03/2035, among others, with specified vesting schedules.
Vita Coco (COCO) reported insider activity by Chief Operating Officer Jonathan Burth. On 10/29/2025, he exercised stock options at $10.178 per share for 2,334 and 20,000 shares (code M), then sold the same amounts (code S) at weighted average prices of $47.948 and $45.711, respectively, pursuant to a Rule 10b5-1 trading plan.
Following these transactions, Burth directly beneficially owned 76,127 shares of common stock. The filing also lists multiple outstanding non-qualified stock options with stated exercise prices and expirations, including grants expiring between 2029 and 2035, with various vesting schedules as disclosed.
Vita Coco (COCO) CEO and Director Martin Roper filed a Form 4 reporting open-market sales of common stock on 10/29/2025 and 10/30/2025 made under a Rule 10b5-1 trading plan.
Direct transactions included 5,000 shares at a weighted average price of $46.087 on 10/29 and 500 shares at $45.00 on 10/30. Indirect transactions included 5,000 shares at a weighted average $46.108 on 10/29 and 500 shares at $45.00 on 10/30 by the Christopher G. Roper Exempt Family Trust, plus 5,000 shares each on 10/29 by the Peter S. Roper and Thomas L. Roper Exempt Family Trusts at weighted average prices within the disclosed ranges.
Following these transactions, reported beneficial holdings were 281,562 shares (direct), 215,631 (Christopher G. Roper Exempt Family Trust), 216,131 (Peter S. Roper Exempt Family Trust), 216,131 (Thomas L. Roper Exempt Family Trust), and 61,200 (by spouse).
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
